Zwitterionic propargyl-linked antifolates useful for treating bacterial infections
申请人:THE UNIVERSITY OF CONNECTICUT
公开号:US10870625B2
公开(公告)日:2020-12-22
The disclosure provides compounds of the formula I and the pharmaceutically acceptable salts thereof.
The variables, e.g. R1, R2, R3, R4, A, B, J, V, W, M, J and Ar are defined herein. The disclosure also provides pharmaceutical compositions comprising a compound or salt of formula I and a pharmaceutically acceptable carrier, methods of inhibiting dihydrofolate reductase (DHFR) in vitro or in vivo with a compound or salt of formula I, and methods of treating a bacterial infections, fungal infections, and protozoal infections with a compound or salt of formula I. A compound or salt of formula I can be the first and only active ingredient used in a pharmaceutical composition or method of this disclosure or may be combined with one or more additional active ingredients that are not compounds or salts of formula I.
本公开提供了式 I 化合物及其药学上可接受的盐类。
变量,如 R1、R2、R3、R4、A、B、J、V、W、M、J 和 Ar 在此定义。本公开还提供了包含式 I 的化合物或盐和药学上可接受的载体的药物组合物,用式 I 的化合物或盐在体外或体内抑制二氢叶酸还原酶 (DHFR) 的方法,以及用式 I 的化合物或盐治疗细菌感染、真菌感染和原生动物感染的方法。式 I 的化合物或盐可以是本公开的药物组合物或方法中使用的第一种和唯一的活性成分,也可以与一种或多种不是式 I 的化合物或盐的其它活性成分结合使用。